It is contraindicated for patients with hypersensitivity, hypercalcemia, renal impairment, or sarcoidosis
mobile IV hydration therapy market reached approximately $568.5 million in 2024 and is projected to expand at a 10.4% CAGR through 2030
(29733464) Lacosamide has several advantages over valproic acid and fosphenytoin, including excellent safety, minimal drug-drug interactions, and reliable pharmacokinetics
Figure 3: Changes in the lameness period amongst the four experimental treatment groups
Table of Contents: What is Vitamin B12, and what does it do in the body
In skeletal muscle, promotes stem cell proliferation, regeneration, and muscle fiber hypertrophy post-injury 1